The investment seeks capital growth... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeGrowth
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SHSAX | 66.77 | 0.64 | +0.97% |
| BlackRock Health Sciences Opps Inv A | |||
| POLEX | 10.15 | 0.01 | +0.10% |
| Polar Capital Emerging Market Strs Instl | |||
| ALABX | 13.55 | N/A | N/A |
| ALPS/Smith Balanced Opportunity A | |||
| FBTTX | 33.48 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||
| GLVIX | 96.86 | -0.12 | -0.12% |
| Invesco Global Focus R6 | |||
A.I.dvisor indicates that over the last year, AFCMX has been closely correlated with AEPCX. These tickers have moved in lockstep 95% of the time. This A.I.-generated data suggests there is a high statistical probability that if AFCMX jumps, then AEPCX could also see price increases.
| Ticker / NAME | Correlation To AFCMX | 1D Price Change % | ||
|---|---|---|---|---|
| AFCMX | 100% | +0.26% | ||
| AEPCX - AFCMX | 95% Closely correlated | +0.76% | ||
| AEPGX - AFCMX | 92% Closely correlated | +0.75% | ||
| RERAX - AFCMX | 91% Closely correlated | +0.76% | ||
| AEGFX - AFCMX | 91% Closely correlated | +0.76% | ||
| REREX - AFCMX | 91% Closely correlated | +0.76% | ||
More | ||||